SEC Form 4 · accession 0001209191-17-027909
Forte Biosciences, Inc. · FBRX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Harry E Gruber
Officer — President, Research & Devel · Director
Period of report
Apr 19, 2017
Accepted (ET)
Apr 21, 2017 · 5:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001419041
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Apr 19, 2017 | P | 25,000 | $10.00 | A | 417,753 | I | By The Harry Edward Gruber and Joan Diane Cunningham Trust, dated 7/12/1988 |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares were purchased at the Issuer's initial public offering.